DCE-MRI对局部进展期乳腺癌新辅助化疗的临床指导价值研究  

Clinical Value of DCE-MRI in Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer

作　　者：屈欣然 QU Xin-ran(Graduate School of Qinghai University,Xining 810016,Qinghai,China)

机构地区：[1]青海大学研究生院,青海西宁810016

出　　处：《医学信息》2018年第4期34-37,共4页Journal of Medical Information

摘　　要：目前新辅助化疗作为局部进展期乳腺癌的标准治疗方式之一,临床应用愈加广泛,如何及时、有效并准确地评价其化疗疗效至关重要。近年来多种成像方法均可以显示肿块化疗前后的变化情况,但有局限性,DCE-MRI在评估新辅助化疗疗效、检测残余病灶、指导保乳手术、预测患者预后中无可代替,本文旨在DCE-MRI定量及半定量评价指标对乳腺癌新辅助化疗的临床指导价值进行综述。Nowadays,neoadjuvant chemotherapy is one of the standard treatments for locally advanced breast cancer.The clinical application of neoadjuvant chemotherapy is more and more extensive.How to evaluate its curative effect in a timely,effective and accurate manner is of crucial importance.In recent years,a variety of imaging methods can show the changes before and after mass chemotherapy,but there are limitations,DCE-MRI in assessing the efficacy of neoadjuvant chemotherapy,detection of residual lesions,breast-conserving surgery guidance,predict the prognosis of patients is irreplaceable.The clinical value of DCE-MRI quantitative and semi-quantitative evaluation of neoadjuvant chemotherapy for breast cancer is reviewed.

关 键 词：局部进展期乳腺癌 新辅助化疗 DCE-MRI 定量参数 半定量参数 

分 类 号：R737.9[医药卫生—肿瘤]